References
1. Freedman RR. Hot flashes: behavioral treatments, mechanisms, and relation to sleep. The American journal of medicine. 2005 Dec 19;118 Suppl 12B:124-30.
2. Maclennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane database of systematic reviews (Online). 2004 Oct 18(4):CD002978.
3. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. Jama. 2002 Jul 17;288(3):321-33.
4. Kargozar R, Azizi H, Salari R. A review of effective herbal medicines in controlling menopausal symptoms. Electron Physician. 2017 Nov;9(11):5826-33.
5. Albertazzi P. A review of non-hormonal options for the relief of menopausal symptoms. Treat Endocrinol. 2006;5(2):101-13.
6. Singh P, Oehler MK. Hormone replacement after gynaecological cancer. Maturitas. 2010 Mar;65(3):190-7.
7. Biglia N, Mariani L, Marenco D, Robba C, Peano E, Kubatzki F, et al. Hormonal replacement therapy after gynaecological cancer. Gynakologisch-geburtshilfliche Rundschau. 2006;46(4):191-6.
8. Morales L, Neven P, Timmerman D, Christiaens MR, Vergote I, Van Limbergen E, et al. Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anticancer Drugs. 2004 Sep;15(8):753-60.
9. Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med. 2006 Jul 24;166(14):1453-65.
10. Freedman RR. Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes. Fertility and sterility. 1998 Aug;70(2):332-7.
11. Freedman RR, Woodward S, Sabharwal SC. Alpha 2-adrenergic mechanism in menopausal hot flushes. Obstetrics and gynecology. 1990 Oct;76(4):573-8.
12. Berendsen HH. The role of serotonin in hot flushes. Maturitas. 2000 Oct 31;36(3):155-64.
13. Blum I, Vered Y, Lifshitz A, Harel D, Blum M, Nordenberg Y, et al. The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women. Israel journal of medical sciences. 1996 Dec;32(12):1158-62.
14. Lippert TH, Filshie M, Muck AO, Seeger H, Zwirner M. Serotonin metabolite excretion after postmenopausal estradiol therapy. Maturitas. 1996 May;24(1-2):37-41.
15. Miller AL. The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern Med Rev. 2008 Sep;13(3):216-26.
16. Brocardo PS, Budni J, Kaster MP, Santos AR, Rodrigues AL. Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Neuropharmacology. 2008 Feb;54(2):464-73.
17. Lucock MD, Green M, Levene MI. Methylfolate modulates potassium evoked neuro-secretion: evidence for a role at the pteridine cofactor level of tyrosine 3-hydroxylase. Neurochemical research. 1995 Jun;20(6):727-36.
18. Botez MI, Young SN, Bachevalier J, Gauthier S. Effect of folic acid and vitamin B12 deficiencies on 5-hydroxyindoleacetic acid in human cerebrospinal fluid. Annals of neurology. 1982 Nov;12(5):479-84.
19. Gaweesh SS, Abdel-Gawad MM, Nagaty AM, Ewies AA. Folic acid supplementation may cure hot flushes in postmenopausal women: a prospective cohort study. Gynecol Endocrinol. 2010 Sep;26(9):658-62.
20. Grodnitskaya E, Kurtser MA. Effect of folic acid supplementation on hot flushes in healthy menopausal women. Climacteric. 2011 Jun 2011;14:87.
21. Bani S, Hasanpour S, Farzad Rik L, Hasankhani H, Sharami SH. The effect of folic Acid on menopausal hot flashes: a randomized clinical trial. J Caring Sci. 2013 Jun;2(2):131-40.
22. Jahdi F, Chamani M, Neisani SL, Haghani H, Mojab F. Comparing the effect of Omega3 and that of Folic Acid on menopause-related hot flashes. Complementary Medicine Journal. 2018;3(28):2353.
23. Gaweesh S, Ewies AA. Folic acid supplementation cures hot flushes in postmenopausal women. Med Hypotheses. 2010 Feb;74(2):286-8.
24. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol. 2001 Dec 1;19(23):4280-90.
25. (MHRA) MaHpRA. Find product information about medicines. Last accessed 28 December 2019 on: https://wwwgovuk/government/organisations/medicines-and-healthcare-products-regulatory-agency. 2019.
26. Greene JG. A factor analytic study of climacteric symptoms. J Psychosom Res. 1976;20(5):425-30.
27. Greene JG, Cooke DJ. Life stress and symptoms at the climacterium. Br J Psychiatry. 1980 May;136:486-91.
28. Greene JG. Constructing a standard climacteric scale. Maturitas. 1998 May 20;29(1):25-31.
29. Utian WH, Janata JW, Kingsberg SA, Schluchter M, Hamilton JC. The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to quantify quality of life through and beyond menopause. Menopause (New York, NY. 2002 Nov-Dec;9(6):402-10.
30. Little R, Yau L. Intent-to-Treat Analysis for Longitudinal Studies with Drop-Outs. Biometrics. 1996;52(4):1324-33.
31. Bottiglieri T. Homocysteine and folate metabolism in depression. Progress in neuro-psychopharmacology & biological psychiatry. 2005 Sep;29(7):1103-12.
32. Bottiglieri T, Hyland K, Laundy M, Godfrey P, Carney MW, Toone BK, et al. Folate deficiency, biopterin and monoamine metabolism in depression. Psychological medicine. 1992 Nov;22(4):871-6.
33. Abou-Saleh MT, Anderson DN, Collins J, Hughes K, Cattell RJ, Hamon CG, et al. The role of pterins in depression and the effects of antidepressive therapy. Biological psychiatry. 1995 Oct 1;38(7):458-63.
34. Hyndman ME, Verma S, Rosenfeld RJ, Anderson TJ, Parsons HG. Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. American journal of physiology. 2002 Jun;282(6):H2167-72.
35. Botez MI, Young SN, Bachevalier J, Gauthier S. Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat. Nature. 1979 Mar 8;278(5700):182-3.
36. Korevaar WC, Geyer MA, Knapp S, Hsu LL, Mandell AJ. Regional distribution of 5-methyltetrahydrofolic acid in brain. Nature: New biology. 1973 Oct 24;245(147):244-5.
37. Butterworth CE, Jr., Tamura T. Folic acid safety and toxicity: a brief review. The American journal of clinical nutrition. 1989 Aug;50(2):353-8.
38. Hellstrom L. Lack of toxicity of folic acid given in pharmacological doses to healthy volunteers. Lancet. 1971 Jan 9;1(7689):59-61.
39. Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, Lonn E, et al. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet. Mar 23;381(9871):1029-36.